期刊文献+

变应原免疫疗法的机制研究进展

暂未订购
导出
摘要 变应原免疫疗法(allergen immunotherapy,AIT),又称脱敏疗法,它是目前治疗过敏性疾病的主要治疗方法之一。经过近百年的临床实践应用,已经取得了肯定的治疗效果,但其机制至今尚未完全阐明。本文就AIT的机制研究进展作一综述。
作者 俞雪 郭胤仕
出处 《现代免疫学》 CAS CSCD 北大核心 2007年第5期430-433,共4页 Current Immunology
基金 上海市青年科技启明星课题(02QB14035) 上海市卫生局青年课题资助项目(024Y14)
  • 相关文献

参考文献27

  • 1Kussebi F,Karamloo F,Akdis M,et al.Advances in immunological treatment of allergy[J].Curr Med Chem,2003,2(4):297-308.
  • 2Durham SR,Walker SM,Varga EM.Long-term clinical efficacy of grass-pollen immunotherapy[J].N Engl J Med,1999,341(7):468-475.
  • 3Shi HN,Walker WA.T helper cell subclasses and clinical disease states[J].Curr Opin Gastroenterol,2002,18(6):711-716.
  • 4Oda N,Minoguchi K,Takeno M,et al.Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy[J].Cell Immunol,1998,190(1):43 -50.
  • 5De Amici M,Puggioni F,Casali L,et al.Variations in serum levels of interleukin (IL)-1beta,IL-2,IL-6,and tumor necrosis factor-alpha during specific immunotherapy[J].Ann Allergy Asthma Immunol,2001,86(3):311-313.
  • 6Taylor A,Verhagen J,Akdis CA,et al.T regulatory cells in allergy and health:a question of allergen specificity and balance[J].Int Arch Allergy Immunol,2004,135(1):73-82.
  • 7Akbari O,Stock P,Dekruyff RH,et al.Role of regulatory T cells in allergy and asthma[J].Curr Opin Immunol,2003,15:627-633.
  • 8Akdis M,Verhagen J,Taylor A,et al.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells[J].J Exp Med,2004,199(11):1567-1575.
  • 9Nouri-Aria KT,Wachholz PA,Francis JN,et al.Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity[J].J Immunol,2004,172(5):3252-3259.
  • 10Akdis CA,Blesken T,Akdis M,et al.Role of interleukin 10 in specific immunotherapy[J].J Clin Invest,1998,102(1):98-106.

二级参考文献22

  • 1Moreno C,Cuesta-Herranz J Fernandez-Tavora L,et al.Immunotherapy safety:a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases.Clin-Exp-Allergy,2004 ; 34 (4):527 ~ 31
  • 2Agostinis F,Tellarini L,Canonica GW,et al.Safety of sublingual immunotherapy with a monomeric allergoid in very young children.Allergy,2005 ; 60 (1):133
  • 3Nouri-Aria KT,Wachholz PA,Francis JN,et al.Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.J Immunol,2004 ; 172(5):3252~3259
  • 4Hall G,Houghton CG,Rahbek JU,et al.Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production.Vaccine,2003,21 (5-6):549 ~ 61
  • 5Marshall JD,Abtahi S,Eiden JJ,et al.Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy.J Allergy Clin Immunol,2001; 108(2):191 ~ 197
  • 6Tulic MK,Fiset PO,Christodoulopoulos P,et al.Amb a 1-immunostimulatory loigodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.J Allergy Clin Immunol,2004;113(2):235~241
  • 7Ferreira F,Wallner M,Breiteneder H,et al.Genetic engineering or allergens ;future therapeutic products.Int Arch Allergy Immunol,2002,12(3):171~178
  • 8Linhart B,Valenta R.Vaccine engineering improved by hybrid technology.Int Arch Allergy Immunol,2004; 134(4):324~331
  • 9Jacquet,A;Magi,M;Haumont,-M;et al.Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p1.Clin-Exp-Allergy.2003 ;33(2):218~25
  • 10Alvarez-Cuesta,E.Gonzelez-Mancebo,E.Immunotherapy in bronchial asthma.Curr Opin Pulm Med,2000,6(1):50~54

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部